1-8 of 8
Wenjing Tao, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel ARC//IL1β/PGE2/β-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML

Bing Z Carter, PhD, Po Yee Mak, Xiangmeng Wang, PhD, Hong Mu, MD PhD, Wenjing Tao, PhD, Vivian Ruvolo, PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3776.
https://doi.org/10.1182/blood.V130.Suppl_1.3776.3776
Published: 2017
Journal Articles

Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 in AML

Xiangmeng Wang, PhD, Po Yee Mak, Hong Mu, MD PhD, Wenjing Tao, PhD, Jonathan A Pachter, PhD, David T Weaver, PhD, Bing Xu, Michael Andreeff, MD PhD, Bing Z Carter, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2653.
https://doi.org/10.1182/blood.V130.Suppl_1.2653.2653
Published: 2017
Journal Articles

Allosteric Bcr-Abl Inhibitor ABL001 Overcomes Bcr-Abl Tyrosine Kinase Inhibitor Resistance and Enhances MDM2 Inhibitor CGM097 Activity in Blast Crisis CML Cells

Wenjing Tao, PhD, Po Yee Mak, Michael Andreeff, MD PhD, Bing Z Carter, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1586.
https://doi.org/10.1182/blood.V130.Suppl_1.1586.1586
Published: 2017
Journal Articles

Activation of p53 Enhances Antileukemia Activity of Bcr-Abl Tyrosine Kinase Inhibitors in a Murine Model of CML

Bing Z Carter, PhD, Po Yee Mak, Hong Mu, MD PhD, Duncan Mak, Ej Dettman, Michael Cardone, Xiangmeng Wang, PhD, Wendy Schober, Wenjing Tao, PhD, Takahiko Seki, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4170.
https://doi.org/10.1182/blood.V130.Suppl_1.4170.4170
Published: 2017
Journal Articles

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Bo Wang, MD, Liang Zhang, MD PhD, Lan Pham, PhD, Wenjing Tao, PhD, Hui Zhang, Jingmeng Xie, Wendy Chen, Qingqing Cai, MD PhD, Dehui Zou, MD PhD, Donglu Zhao, MD, Xiuhua Sun, MDPhD, Rong Liang, MD PhD, Jack Wang, Krystle Nomie, PhD, Nathan Fowler, MD, Michael Wang, MD
Journal: Blood
Blood (2015) 126 (23): 5126.
https://doi.org/10.1182/blood.V126.23.5126.5126
Published: 2015
Journal Articles

Developing Novel Therapeutic Strategies to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Lan Pham, PhD, Liang Zhang, MD PhD, Wenjing Tao, PhD, Donglu Zhao, MD, Hui Zhang, Jingmeng Xie, Jack Wang, Krystle Nomie, PhD, Michael Wang, MD
Journal: Blood
Blood (2015) 126 (23): 707.
https://doi.org/10.1182/blood.V126.23.707.707
Published: 2015
Journal Articles

Oncogenic Transformation of NIH 3T3 Fibroblasts by BCR-ABL Oncoprotein Requires the IL-3 Receptor.

Wenjing Tao, PhD, Hui Lin, MD, Tong Sun, MS, Ajoy K. Samanta, PhD, Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2007) 110 (11): 3370.
https://doi.org/10.1182/blood.V110.11.3370.3370
Published: 2007
Journal Articles

The ATP Competitor INNO-406 (NS-187) Inhibits Proliferation and Survival of Mouse Cells Expressing Several Immatinib Mesylate Resistant Bcr/Abl Mutants and Cells from CML Patients.

Wenjing Tao, PhD, Tong Sun, MS, Adam R. Craig, MD, PhD, Jorge E. Cortes, MD, Oliver G. Ottmann, MD, Andreas Hochhaus, MD, Premkumar E. Reddy, PhD, Hagop M. Kantarjian, MD, Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2006) 108 (11): 2179.
https://doi.org/10.1182/blood.V108.11.2179.2179
Published: 2006